D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 9.69% |
| 2 | Consumer Discretionary | 9.53% |
| 3 | Technology | 9.28% |
| 4 | Healthcare | 8.29% |
| 5 | Financials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXPR
1176
DELISTED
Express, Inc.
EXPR
| $6.78M | 0.01% |
20,498
+14,361
| +234% | +$4.16M |
|
1177
Tanger
SKT
$4.82B
| $6.76M | 0.01% |
192,291
-99,407
| -34% | -$3.71M |
|
1178
Helmerich & Payne
HP
$3.53B
| $6.76M | 0.01% |
99,300
-69,144
| -41% | -$4.52M |
|
|
XLNX
1179
CALL
DELISTED
Xilinx Inc
XLNX
| $6.75M | 0.01% |
159,500
-239,100
| -60% | -$9.8M |
|
1180
CALL
Qualcomm
QCOM
$176B
| $6.74M | 0.01% |
97,200
-266,200
| -73% | -$18.8M |
|
|
GIMO
1181
DELISTED
Gigamon Inc.
GIMO
| $6.73M | 0.01% |
316,995
+65,352
| +26% | +$1.26M |
|
|
XOXO
1182
DELISTED
Xo Group Inc
XOXO
| $6.73M | 0.01% |
380,927
+12,840
| +3% | +$217K |
|
|
FCH
1183
DELISTED
Felcor Lodging Trust
FCH
| $6.72M | 0.01% |
584,885
-47,350
| -7% | -$510K |
|
1184
Incyte
INCY
$23.5B
| $6.71M | 0.01% |
73,173
+20,528
| +39% | +$1.7M |
|
|
SF
1185
Stifel
SF
$12.3B
| $6.7M | 0.01% |
270,554
+128,347
| +90% | +$2.96M |
|
1186
PUT
Honeywell
HON
$77.1B
| $6.7M | 0.01% |
71,448
-314,949
| -82% | -$28.8M |
|
1187
IMAX
IMAX
$2.38B
| $6.69M | 0.01% |
198,460
+96,497
| +95% | +$3.21M |
|
1188
CALL
Illumina
ILMN
$29.4B
| $6.68M | 0.01% |
37,008
-60,241
| -62% | -$11.3M |
|
1189
PUT
Avis
CAR
$5.63B
| $6.67M | 0.01% |
113,000
-112,300
| -50% | -$6.85M |
|
|
PARA
1190
PUT
DELISTED
Paramount Global Class B
PARA
| $6.67M | 0.01% |
110,000
-418,400
| -79% | -$24.4M |
|
1191
CALL
Cardinal Health
CAH
$53.4B
| $6.65M | 0.01% |
73,700
| – | – |
|
|
MCRL
1192
DELISTED
MICREL INC
MCRL
| $6.65M | 0.01% |
441,091
+431,027
| +4,283% | +$6.3M |
|
1193
PUT
Bristol-Myers Squibb
BMY
$127B
| $6.64M | 0.01% |
103,000
-627,900
| -86% | -$39.3M |
|
1194
CALL
Perrigo
PRGO
$1.4B
| $6.62M | 0.01% |
40,000
| – | – |
|
|
INFI
1195
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $6.62M | 0.01% |
473,576
+95,103
| +25% | +$1.45M |
|
1196
CALL
Expedia Group
EXPE
$31.2B
| $6.62M | 0.01% |
70,300
| – | – |
|
1197
Regis Corp
RGS
$69.9M
| $6.59M | 0.01% |
20,150
-8,685
| -30% | -$2.83M |
|
|
UNT
1198
DELISTED
UNIT Corporation
UNT
| $6.59M | 0.01% |
235,651
-81,033
| -26% | -$2.41M |
|
1199
MasTec
MTZ
$26.7B
| $6.53M | 0.01% |
338,179
+209,349
| +163% | +$4.19M |
|
|
STJ
1200
PUT
DELISTED
St Jude Medical
STJ
| $6.52M | 0.01% |
99,700
-34,200
| -26% | -$2.27M |
|
Similar funds
D.E. Shaw & Co's Q1 2015 Portfolio in Review
As of Q1 2015, D.E. Shaw & Co held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 9.7% of assets, up from 8% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, D.E. Shaw & Co opened a new position in SPDR Gold Trust worth $231M.
- D.E. Shaw & Co's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- D.E. Shaw & Co's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- D.E. Shaw & Co fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- D.E. Shaw & Co opened 448 new positions and closed 828 in Q1 2015.
- D.E. Shaw & Co's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.